Acid Suppressant Market: Is Rising GERD Prevalence Sustaining Long-Term Demand Despite PPI Safety Concerns?
Acid suppressant therapy's chronic disease anchor — the proton pump inhibitors (PPIs), H2 receptor antagonists, and emerging potassium-competitive acid blockers (P-CABs) used to manage gastroesophageal reflux disease, peptic ulcer disease, and related acid-related gastrointestinal disorders — represents one of the largest and most consistently utilized therapeutic categories in...
0 Commentarii 0 Distribuiri 2 Views 0 previzualizare
BuzzingAbout https://www.buzzingabout.com